Mikhail Eydelman - Jun 7, 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP, Gen Counsel & Corp Sec
Signature
Mikhail Eydelman, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Jun 7, 2023
Transactions value $
-$33,056
Form type
4
Date filed
6/9/2023, 04:24 PM
Previous filing
Mar 3, 2023
Next filing
Sep 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability -$33.1K -645 -2.89% $51.25 21.7K Jun 7, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.
F2 Includes 539 shares acquired under the Vaxcyte, Inc. Employee Stock Purchase Plan on May 17, 2023.